Key evaluationQuestionsGroup 3

Barriers andenablers

KEQ2. What factors hindered or enabled the implementation of actions in the Plan?

KEQ5. What factors hindered or enabled the achievement of the Plan’s stated objectives/contribution to the intended outcomes?

Key messages

  • A common set of structural factors shapes both implementation and outcomes

    The same system-level enablers and barriers influence both the delivery of Plan actions (KEQ2) and the achievement of intended outcomes (KEQ5), with enablers accelerating progress and barriers constraining implementation and longer-term impact if not addressed.

  • Key enablers of implementation

    Implementation has been enabled by the Plan's authorising environment and shared strategic direction; dedicated funding, partnership and sector collaboration; jurisdiction-level engagement and dedicated cancer agencies; and Cancer Australia's national leadership and coordinating role.

  • Key barriers to implementation

    The absence of dedicated, sustained implementation funding is the most consistently reported barrier. Other barriers to implementation identified by stakeholders include fragmented data systems, governance complexity and unclear roles within a federated system, workforce and organisational capacity constraints, and implementation challenges specific to Aboriginal and Torres Strait Islander stakeholders and organisations.

Summary of implementation enablers and barriers

Enablers

Barriers

Authorising environment and shared direction

Insufficient and fragmented funding

Dedicated funding, partnerships and sector collaboration

Fragmented and underdeveloped data systems

Jurisdiction-level engagement and dedicated cancer agencies

Federated governance complexity and unclear roles

Cancer Australia’s national leadership and coordinating role

Workforce and organisational capacity constraints

Unique challenges for Aboriginal and Torres Strait Islander peoples

System-level enablers

Stakeholders identified Australian Government endorsement of the Plan, and the shared strategic direction it provides, as a foundational enabler of implementation. The Plan’s status as a nationally endorsed framework enabled organisations to justify priorities, align activity, and strengthen funding bids in ways that voluntary frameworks cannot replicate. The Plan's shared priorities, language, and policy narrative provided a nationally recognised reference point that organisations could draw on to support advocacy, partnership development, funding proposals, and policy negotiation. Stakeholders reported that where this authorising environment was actively leveraged, organisations were better positioned to act on and justify alignment with Plan priorities and account for that action to funders, governments, and partners.

That authorising environment — the policies set at the national level — means that the state can leverage off that and advocate, because that's setting the scene for us.
Cancer sector stakeholder in consultation
That authorising environment — the policies set at the national level — means that the state can leverage off that and advocate, because that's setting the scene for us.
Cancer sector stakeholder in consultation
It has definitely informed the organisation and our strategic direction.
Cancer sector stakeholder in consultation
The Plan has enabled us to focus specifically on those identified groups in the Plan.
Cancer sector stakeholder in survey
It's a roadmap — as a sector, we've all agreed this is where we want to go.
Cancer sector stakeholder in consultation

Authorising environment and shared direction

Stakeholders identified Australian Government endorsement of the Plan, and the shared strategic direction it provides, as a foundational enabler of implementation. The Plan’s status as a nationally endorsed framework enabled organisations to justify priorities, align activity, and strengthen funding bids in ways that voluntary frameworks cannot replicate. The Plan's shared priorities, language, and policy narrative provided a nationally recognised reference point that organisations could draw on to support advocacy, partnership development, funding proposals, and policy negotiation. Stakeholders reported that where this authorising environment was actively leveraged, organisations were better positioned to act on and justify alignment with Plan priorities and account for that action to funders, governments, and partners.

That authorising environment — the policies set at the national level — means that the state can leverage off that and advocate, because that's setting the scene for us.
Cancer sector stakeholder in consultation
That authorising environment — the policies set at the national level — means that the state can leverage off that and advocate, because that's setting the scene for us.
Cancer sector stakeholder in consultation
It has definitely informed the organisation and our strategic direction.
Cancer sector stakeholder in consultation
The Plan has enabled us to focus specifically on those identified groups in the Plan.
Cancer sector stakeholder in survey
It's a roadmap — as a sector, we've all agreed this is where we want to go.
Cancer sector stakeholder in consultation

Dedicated funding, partnership and sector collaboration

Dedicated funding and formal partnership structures were identified as the most direct enablers of on-the-ground implementation, helping to convert strategic intent into coordinated activity. Funded initiatives and grant programs, including the Australian Cancer Nursing and Navigation Program, Partnerships for Culturally Safe Cancer Care grant program, and MRFF-aligned grant rounds, were consistently reported as enabling organisations to initiate, scale, and sustain the Plan’s implementation activity that would otherwise not have been possible within existing operational budgets.

Formal partnership structures — particularly the Implementation Partnership model — were identified as important mechanisms for translating goodwill and informal collaboration into defined commitments and coordinated action. Stakeholders noted that collaboration was most productive and most likely to drive implementation when linked to specific funding streams, accountability arrangements, and formal agreements. Where these structures were absent, collaboration was often more diffuse and harder to sustain over time.

Funding has been the biggest enabler.
Cancer sector stakeholder in survey
Funding has been the biggest enabler.
Cancer sector stakeholder in survey
We couldn't do this work — we couldn't deliver this program — without having the backbone that the cancer plan provides and the partnership that we have with Cancer Australia.
Aboriginal and Torres Strait Islander stakeholder in consultation
Using the Australian Cancer Plan to understand what the expectation was — and then being able to use that to provide feedback and leverage for funding [has been a real enabler].
Jurisdictional stakeholder in consultation
The specific projects that we have going are heavily leveraged off the grants that Cancer Australia has provided — and we're very grateful for the targeted support towards First Nations health and the opportunity to innovate in that space.
Jurisdictional stakeholder in consultation

Jurisdiction-level engagement and dedicated cancer agencies

In addition to the foundational system reforms, state and territory cancer agencies and dedicated jurisdictional cancer governance, networks and programs were identified as key enablers of implementation. They serve as intermediaries, translating national direction into local action. Their capacity to maintain institutional knowledge, coordinate across health service providers, and align jurisdictional cancer plans with the Plan was consistently highlighted as essential to sustained implementation progress. Stakeholders noted that jurisdictions with dedicated cancer agencies or established cancer networks were better positioned to engage with and act on Plan priorities, with implications for consistency of implementation across jurisdictions.

A dedicated agency to take responsibility — that's an incredible enabler.
Cancer sector stakeholder in consultation
A dedicated agency to take responsibility — that's an incredible enabler.
Cancer sector stakeholder in consultation
We have been an active and early partner in implementing the National Lung Cancer Screening Program — doing a lot of work with service readiness planning with primary care and diagnostic imaging and working within public hospital services.
Jurisdictional stakeholder in consultation
South Metropolitan Health Service has already aligned itself to the Australian Cancer Plan and released that in its own health service provider cancer plan. WA Country Health has done the same.
Jurisdictional stakeholder in consultation
Being part of the NCEG and the ACCN, and other things that have come from Cancer Australia, is part of having a cancer plan and making it more meaningful, reaching out to the networks and engaging with people at the coalface.
Jurisdictional stakeholder in consultation

Cancer Australia's national leadership and coordinating role

Cancer Australia's role as a dedicated national cancer agency was consistently identified as a distinct enabler of implementation — extending beyond the Plan itself through its influence, leadership, and active engagement with jurisdictions, convening sector partners, building capability, and maintaining relationships across the cancer control system.

This leadership and coordinating role was reflected in a range of ways in practice, including the establishment of national initiatives such as the ACCN, the generation and brokering of evidence through data initiatives, reports, standards and frameworks, and active support for jurisdictional alignment and implementation.

This coordinating role was particularly valued by smaller organisations and less-resourced jurisdictions, where Cancer Australia's direct engagement provided implementation support that complemented – and in some cases supplemented – existing state and territory infrastructure and capacity. Stakeholders across all groups consistently regarded Cancer Australia's leadership as a significant factor in enabling coordinated national action and strengthening system-wide coherence in cancer control, with its effectiveness as a convener and relationship-builder consistently cited as a genuine system asset.

It's been really useful for us as an isolated team. There's not 50 cancer centres in our local area, there's three and that's it. So it's great to have that resourcing.
Jurisdiction stakeholder in consultation
It's been really useful for us as an isolated team. There's not 50 cancer centres in our local area, there's three and that's it. So it's great to have that resourcing.
Jurisdiction stakeholder in consultation
Since I've been in this position, there's been a lot more engagement and a lot of opportunity available to us — and because we're so isolated, it's really good to have that national lens shared with us.
Jurisdictional stakeholder in consultation
We have a great relationship and I think we've been working really effectively with Cancer Australia — and that's one of the things that gives me a great deal of hope that the Cancer Data Framework is not going to sit on a shelf.
Commonwealth stakeholder in consultation
Cancer Australia have been an amazing partner – they're not just passionate about it, they’re actually really effective in driving the change they want to see.
Cancer sector stakeholder in consultation

System-level enablers

Stakeholders identified Australian Government endorsement of the Plan, and the shared strategic direction it provides, as a foundational enabler of implementation. The Plan’s status as a nationally endorsed framework enabled organisations to justify priorities, align activity, and strengthen funding bids in ways that voluntary frameworks cannot replicate. The Plan's shared priorities, language, and policy narrative provided a nationally recognised reference point that organisations could draw on to support advocacy, partnership development, funding proposals, and policy negotiation. Stakeholders reported that where this authorising environment was actively leveraged, organisations were better positioned to act on and justify alignment with Plan priorities and account for that action to funders, governments, and partners.

That authorising environment — the policies set at the national level — means that the state can leverage off that and advocate, because that's setting the scene for us.
Cancer sector stakeholder in consultation
That authorising environment — the policies set at the national level — means that the state can leverage off that and advocate, because that's setting the scene for us.
Cancer sector stakeholder in consultation
It has definitely informed the organisation and our strategic direction.
Cancer sector stakeholder in consultation
The Plan has enabled us to focus specifically on those identified groups in the Plan.
Cancer sector stakeholder in survey
It's a roadmap — as a sector, we've all agreed this is where we want to go.
Cancer sector stakeholder in consultation

Authorising environment and shared direction

Stakeholders identified Australian Government endorsement of the Plan, and the shared strategic direction it provides, as a foundational enabler of implementation. The Plan’s status as a nationally endorsed framework enabled organisations to justify priorities, align activity, and strengthen funding bids in ways that voluntary frameworks cannot replicate. The Plan's shared priorities, language, and policy narrative provided a nationally recognised reference point that organisations could draw on to support advocacy, partnership development, funding proposals, and policy negotiation. Stakeholders reported that where this authorising environment was actively leveraged, organisations were better positioned to act on and justify alignment with Plan priorities and account for that action to funders, governments, and partners.

That authorising environment — the policies set at the national level — means that the state can leverage off that and advocate, because that's setting the scene for us.
Cancer sector stakeholder in consultation
That authorising environment — the policies set at the national level — means that the state can leverage off that and advocate, because that's setting the scene for us.
Cancer sector stakeholder in consultation
It has definitely informed the organisation and our strategic direction.
Cancer sector stakeholder in consultation
The Plan has enabled us to focus specifically on those identified groups in the Plan.
Cancer sector stakeholder in survey
It's a roadmap — as a sector, we've all agreed this is where we want to go.
Cancer sector stakeholder in consultation

Dedicated funding, partnership and sector collaboration

Dedicated funding and formal partnership structures were identified as the most direct enablers of on-the-ground implementation, helping to convert strategic intent into coordinated activity. Funded initiatives and grant programs, including the Australian Cancer Nursing and Navigation Program, Partnerships for Culturally Safe Cancer Care grant program, and MRFF-aligned grant rounds, were consistently reported as enabling organisations to initiate, scale, and sustain the Plan’s implementation activity that would otherwise not have been possible within existing operational budgets.

Formal partnership structures — particularly the Implementation Partnership model — were identified as important mechanisms for translating goodwill and informal collaboration into defined commitments and coordinated action. Stakeholders noted that collaboration was most productive and most likely to drive implementation when linked to specific funding streams, accountability arrangements, and formal agreements. Where these structures were absent, collaboration was often more diffuse and harder to sustain over time.

Funding has been the biggest enabler.
Cancer sector stakeholder in survey
Funding has been the biggest enabler.
Cancer sector stakeholder in survey
We couldn't do this work — we couldn't deliver this program — without having the backbone that the cancer plan provides and the partnership that we have with Cancer Australia.
Aboriginal and Torres Strait Islander stakeholder in consultation
Using the Australian Cancer Plan to understand what the expectation was — and then being able to use that to provide feedback and leverage for funding [has been a real enabler].
Jurisdictional stakeholder in consultation
The specific projects that we have going are heavily leveraged off the grants that Cancer Australia has provided — and we're very grateful for the targeted support towards First Nations health and the opportunity to innovate in that space.
Jurisdictional stakeholder in consultation

Jurisdiction-level engagement and dedicated cancer agencies

In addition to the foundational system reforms, state and territory cancer agencies and dedicated jurisdictional cancer governance, networks and programs were identified as key enablers of implementation. They serve as intermediaries, translating national direction into local action. Their capacity to maintain institutional knowledge, coordinate across health service providers, and align jurisdictional cancer plans with the Plan was consistently highlighted as essential to sustained implementation progress. Stakeholders noted that jurisdictions with dedicated cancer agencies or established cancer networks were better positioned to engage with and act on Plan priorities, with implications for consistency of implementation across jurisdictions.

A dedicated agency to take responsibility — that's an incredible enabler.
Cancer sector stakeholder in consultation
A dedicated agency to take responsibility — that's an incredible enabler.
Cancer sector stakeholder in consultation
We have been an active and early partner in implementing the National Lung Cancer Screening Program — doing a lot of work with service readiness planning with primary care and diagnostic imaging and working within public hospital services.
Jurisdictional stakeholder in consultation
South Metropolitan Health Service has already aligned itself to the Australian Cancer Plan and released that in its own health service provider cancer plan. WA Country Health has done the same.
Jurisdictional stakeholder in consultation
Being part of the NCEG and the ACCN, and other things that have come from Cancer Australia, is part of having a cancer plan and making it more meaningful, reaching out to the networks and engaging with people at the coalface.
Jurisdictional stakeholder in consultation

Cancer Australia's national leadership and coordinating role

Cancer Australia's role as a dedicated national cancer agency was consistently identified as a distinct enabler of implementation — extending beyond the Plan itself through its influence, leadership, and active engagement with jurisdictions, convening sector partners, building capability, and maintaining relationships across the cancer control system.

This leadership and coordinating role was reflected in a range of ways in practice, including the establishment of national initiatives such as the ACCN, the generation and brokering of evidence through data initiatives, reports, standards and frameworks, and active support for jurisdictional alignment and implementation.

This coordinating role was particularly valued by smaller organisations and less-resourced jurisdictions, where Cancer Australia's direct engagement provided implementation support that complemented – and in some cases supplemented – existing state and territory infrastructure and capacity. Stakeholders across all groups consistently regarded Cancer Australia's leadership as a significant factor in enabling coordinated national action and strengthening system-wide coherence in cancer control, with its effectiveness as a convener and relationship-builder consistently cited as a genuine system asset.

It's been really useful for us as an isolated team. There's not 50 cancer centres in our local area, there's three and that's it. So it's great to have that resourcing.
Jurisdiction stakeholder in consultation
It's been really useful for us as an isolated team. There's not 50 cancer centres in our local area, there's three and that's it. So it's great to have that resourcing.
Jurisdiction stakeholder in consultation
Since I've been in this position, there's been a lot more engagement and a lot of opportunity available to us — and because we're so isolated, it's really good to have that national lens shared with us.
Jurisdictional stakeholder in consultation
We have a great relationship and I think we've been working really effectively with Cancer Australia — and that's one of the things that gives me a great deal of hope that the Cancer Data Framework is not going to sit on a shelf.
Commonwealth stakeholder in consultation
Cancer Australia have been an amazing partner – they're not just passionate about it, they’re actually really effective in driving the change they want to see.
Cancer sector stakeholder in consultation

System-level barriers

The absence of dedicated, sustained implementation funding is the most consistently reported barrier across all stakeholder groups. Funding constraints limit the scale, pace, and sustainability of initiatives, with smaller organisations, priority population sectors, and less-resourced jurisdictions most affected. Stakeholders highlighted a fundamental tension between the Plan's ambitions and available resourcing, with implementation often reliant on short-term project funding or discretionary organisational effort rather than investment explicitly aligned to Plan priorities.

I think the biggest challenge is the funding.
Cancer sector stakeholder in consultation
I think the biggest challenge is the funding.
Cancer sector stakeholder in consultation
The ambition of the plan is not matched by the resourcing available.
Cancer sector stakeholder in survey
The plan clearly lays out things we aim to achieve — there's a gap between those aspirations and the actual dollars that allow that to be done.
Cancer sector stakeholder in consultation
The Plan provides a strong framework but tangible progress requires dedicated investment, clear accountability and nationally coordinated programs aligned to its priority areas.
Cancer sector stakeholder in survey
I'm worried that we'll finish the grant and we won't be able to continue the work.
Jurisdictional stakeholder in consultation
The Plan has shaped our thinking, but not always our capacity to act.
Cancer sector stakeholder in survey

Insufficient and fragmented funding

The absence of dedicated, sustained implementation funding is the most consistently reported barrier across all stakeholder groups. Funding constraints limit the scale, pace, and sustainability of initiatives, with smaller organisations, priority population sectors, and less-resourced jurisdictions most affected. Stakeholders highlighted a fundamental tension between the Plan's ambitions and available resourcing, with implementation often reliant on short-term project funding or discretionary organisational effort rather than investment explicitly aligned to Plan priorities.

I think the biggest challenge is the funding.
Cancer sector stakeholder in consultation
I think the biggest challenge is the funding.
Cancer sector stakeholder in consultation
The ambition of the plan is not matched by the resourcing available.
Cancer sector stakeholder in survey
The plan clearly lays out things we aim to achieve — there's a gap between those aspirations and the actual dollars that allow that to be done.
Cancer sector stakeholder in consultation
The Plan provides a strong framework but tangible progress requires dedicated investment, clear accountability and nationally coordinated programs aligned to its priority areas.
Cancer sector stakeholder in survey
I'm worried that we'll finish the grant and we won't be able to continue the work.
Jurisdictional stakeholder in consultation
The Plan has shaped our thinking, but not always our capacity to act.
Cancer sector stakeholder in survey

Fragmented and underdeveloped data systems

Fragmented, delayed and poorly integrated data systems constrain both implementation and outcome achievement. Without reliable, timely, and linked data, the system cannot effectively monitor progress, target interventions toward areas of greatest need, or demonstrate impact.

Stakeholders identified key data constraints including the absence of a single national data system, delays in cancer registry data, limited integration of patient-reported measures (Patient-Report Experience Measures (PREMs)/Patient Reported Outcome Measures (PROMs)) into routine care, and underutilisation of existing data assets for system learning.

Progress on the Data Framework was recognised as an important step, with stakeholders noting that realising its full potential — alongside other national foundational frameworks — will require sustained, coordinated investment and implementation across governments and sectors.

We cannot measure whether equity gaps are closing — without national data it is difficult to plan workforce and services.
Cancer sector stakeholder in survey
We cannot measure whether equity gaps are closing — without national data it is difficult to plan workforce and services.
Cancer sector stakeholder in survey
Our cancer registry data is about five years lagging. It's hard for me to get truly up-to-date data — and that's not anyone's fault, it's just how the system works.
Jurisdictional stakeholder in consultation
We've got a [data] framework, but unless we can actually implement — same with OCP — how do we actually ensure it reaches the potential that the framework hopes it does?
Cancer sector stakeholder in consultation
We've got the disadvantage of not having a single data system. It's very disjointed, requires data linkage — that's definitely going to require investment. In our federated model, that has to be both Commonwealth and states.
Cancer sector stakeholder in consultation

Federated governance complexity and unclear roles

Australia's federated health system creates persistent complexity in roles, responsibilities and accountability across Commonwealth, state and territory, and sector partners. Stakeholders identified role ambiguity – particularly between Cancer Australia, the Commonwealth Department of Health, Disability and Ageing, and state and territory governments - as a barrier to coordinated implementation, contributing to duplication of effort, inconsistent adoption of Plan priorities, and challenges translating national frameworks into local service delivery contexts. Differences in jurisdictional capacity mean some states are better positioned to implement the Plan than others, with implications for consistency of implementation and equity of outcomes nationally.

If we had a magic wand and we could just coordinate between Commonwealth and states — it's almost like utopia — because there's great work being done at both levels, but it just is not well coordinated.
Cancer sector stakeholder in consultation
If we had a magic wand and we could just coordinate between Commonwealth and states — it's almost like utopia — because there's great work being done at both levels, but it just is not well coordinated.
Cancer sector stakeholder in consultation
Confusion about who does what — Commonwealth versus state versus Cancer Australia — role ambiguity, especially for newer people in the sector. A simple national 'who does what' map would help.
Jurisdictional stakeholder in consultation
A key challenge is driving implementation with the states and territories — they've sort of gone, ‘that's the Australian Cancer Plan, and here's the stuff that we're going to focus on.
Commonwealth stakeholder in consultation
The great strength of the Australian Cancer Plan is that it binds us in a federation, assuming everybody signs up and is authentic in their commitment. But the reality is that no patient is ever treated at the national level — it's all done at state level on the ground.
Jurisdictional stakeholder in consultation
I really worry about SA, Tassie and NT, ACT to some extent — they're just not as able to tackle the implementation of cancer plans quite the same way that Victoria and NSW can. That equity issue between our jurisdictions worries me.
Cancer sector stakeholder in consultation

Workforce and organisational capacity constraints

Workforce shortages and organisational capacity constraints represent a direct limit on the system's ability to deliver and sustain new initiatives. Stakeholders identified shortages in nursing, allied health, and the Aboriginal and Torres Strait Islander cancer care workforce, and in regional, rural and remote settings where services are already under pressure. Implementation activity is frequently undertaken in addition to existing workloads without additional resourcing or dedicated support, contributing to implementation fatigue and uneven progress across settings. Workforce development — including culturally safe training, pipeline investment, and Aboriginal and Torres Strait Islander leadership pathways — was identified as both a significant constraint and a priority for the next phase of the Plan.

Without the workforce we can't deliver all of the other things in the plan.
Cancer sector stakeholder in consultation
Without the workforce we can't deliver all of the other things in the plan.
Cancer sector stakeholder in consultation
Clinician workloads are already very high. This work is done on top of everything else.
Cancer sector stakeholder in survey
We simply do not have the workforce capacity to take on additional unfunded work.
Cancer sector stakeholder in survey
Drawing people to the Northern Territory can be quite challenging — not only for consultants but also for the nursing workforce. We have a very novice cancer nursing workforce and we're quite isolated.
Jurisdictional stakeholder in consultation
There are a lot more conversations now being had about our Aboriginal and Torres Strait Islander workforce being a key component within a patient's cancer journey — knowing that patient through their whole journey, and having the workforce at each stage of that journey.
Aboriginal and Torres Strait Islander stakeholder in consultation

Unique challenges for Aboriginal and Torres Strait Islander people

Aboriginal and Torres Strait Islander stakeholders identified implementation challenges that, while connected to broader system barriers, reflect their distinct position within the cancer control landscape.

The coexistence of the Plan and the NACCHO Aboriginal and Torres Strait Islander Cancer Plan — while broadly understood as complementary — has created some uncertainty about roles, responsibilities, accountability, and where to direct engagement. The absence of clear guidance on how the two plans interact has added to implementation complexity and consultation burden for Aboriginal and Torres Strait Islander stakeholders and organisations.

Stakeholders also identified a consistent mismatch between equity commitments and available implementation support — with insufficient resourcing of the Aboriginal and Torres Strait Islander community-controlled sector, high consultation burden, and limited shared accountability across the broader system. Stakeholders expressed concern that responsibility for achieving equity outcomes may fall disproportionately on under-resourced Aboriginal and Torres Strait Islander organisations, and emphasised that realising the Plan’s equity ambitions will require sustained investment and genuine system-wide accountability.

Very confusing out there — then you have two plans, one for the ACCHO sector, one for the mainstream plan for all of Australia.
Aboriginal and Torres Strait Islander stakeholder in consultation
Very confusing out there — then you have two plans, one for the ACCHO sector, one for the mainstream plan for all of Australia.
Aboriginal and Torres Strait Islander stakeholder in consultation
They're generally all in alignment — it's not that they say different things. But there's a lot of things going on now and a lot more people in this space, and I find it very hard to keep up with what's happening, where, by whom, for what.
Aboriginal and Torres Strait Islander stakeholder in consultation
I know why [the grants are structured this way] — but I think we do have to just think about different people's capacities moving forward. How much more can people keep doing?
Aboriginal and Torres Strait Islander stakeholder in consultation
I'm not sure that was fully appreciated at the beginning — the intention to have everybody interacting and working with First Nations health groups and professionals — that it's a tiny, tiny sector and there's so much burden. I would say that is maybe one of the unintended consequences.
Cancer sector stakeholder (non-Aboriginal and Torres Strait Islander) in consultation